Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.78 |
| ▸ | RXRB | P28702 | 5/20 | 0.78 |
| ▸ | RXRG | P48443 | 4/20 | 0.78 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.67 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.67 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.67 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.67 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.67 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.67 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.61 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3045891 | 0.94 | HDAC1 (0.76) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL4327548 | 0.94 | HDAC1 (0.76) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL18169217 | 0.91 | RXRA (0.94) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL10247702 | 0.85 | HDAC1 (0.64) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL416678 | 0.84 | HDAC1 (0.69) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL8552173 | 0.83 | RXRA (0.63) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL4329559 | 0.82 | HDAC1 (0.77) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL3363018 | 0.82 | RXRA (0.74) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL15606558 | 0.81 | HDAC1 (0.70) | RXRARXRBRXRGHDAC3HDAC1 | |
| SCHEMBL4336859 | 0.81 | HDAC1 (1.00) | RXRARXRBRXRGHDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022054-A1 | NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS | LABORATOIRE BIODIM (FR) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022054-A1 | NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS | HAVCR2, MAVS, EIF2AK2 | RXRA 2199/4885RXRB 2151/4885RXRG 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.